Recent Posts

Combination therapy shows promise in fighting neuroblastoma

A study by a multidisciplinary team of researchers from The Saban Research Institute of Children's Hospital Los Angeles sheds further light on the role of the cytokine TGFβ1 in the growth of neuroblastoma, and suggests the possibility for a small molecule drug/antibody combinatorial therapy to treat this cancer.

Read more here: https://www.eurekalert.org/pub_releases/2016-10/chla-cts101116.php

Archive
Search By Tags

524 Bayfield Street North
P.O. Box 20005
Barrie, ON L4M 5E9
Canada

info@opacc.org

1-888-290-5496

  • Wix Facebook page
  • Wix Twitter page
  • Instagram Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon